Zobrazeno 1 - 10
of 148
pro vyhledávání: '"E Maartense"'
Autor:
E. Meershoek-Klein Kranenbarg, J. van den Bosch, Cjh van de Velde, Judith R. Kroep, G.J. Liefers, A.E. van Leeuwen-Stok, Ejt Rutgers, E. Maartense, E.J. Blok, Hein Putter, M Duym-de Carpentier, J.W.R. Nortier
Publikováno v:
Cancer Research. 77:P2-09
The implementation of adjuvant aromatase inhibitors (AI) has contributed significantly to an ongoing improvement in survival of early breast cancer patients, but the impact of extended AI on toxicity after use in the initial 5 years has not yet been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7b3f4481c5b031d3748011786424eb6
https://doi.org/10.1158/1538-7445.sabcs16-p2-09-08
https://doi.org/10.1158/1538-7445.sabcs16-p2-09-08
Autor:
E. Meershoek-Klein Kranenbarg, E.J. Blok, A.E. van Leeuwen-Stok, J.W.R. Nortier, Ejt Rutgers, G.J. Liefers, Judith R. Kroep, E. Maartense, Cjh van de Velde, Hein Putter, J. van den Bosch
Publikováno v:
Cancer Research. 77:S1-04
Despite the success of adjuvant endocrine therapy in early breast cancer, approximately 50% of all recurrences still occur after the initial 5 years of follow-up. Earlier studies confirmed that endocrine therapy extension after 5 years of adjuvant ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fb3cb6368dbb4d1768289d99b1a9d3a
https://doi.org/10.1158/1538-7445.sabcs16-s1-04
https://doi.org/10.1158/1538-7445.sabcs16-s1-04
Autor:
Soudhir Colote, Demetris Papamichael, Josep Tabernero, Maria Banzi, Armand de Gramont, Aimery de Gramont, Franck Bonnetain, Alex Duval, Benoist Chibaudel, E. Maartense, Thierry André, Jean-Luc Van Laethem, Pieter Demetter, Dewi Vernerey, Göran Carlsson, Marcus Möehler, Einat Shacham Shmueli, Christophe Louvet, Werner Scheithauer, Aurelie Scriva, Tamas Hickish, Jean François Fléjou, Christophe Tournigand, Annemilaï Tijeras-Raballand, Stefania Landolfi
Publikováno v:
Journal of Clinical Oncology. 33:4176-4187
Purpose The MOSAIC (Multicenter International Study of Oxaliplatin/Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer) study has demonstrated 3-year disease-free survival (DFS) and 6-year overall survival (OS) benefit of adjuvant oxali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9318b62c2b3f828171efa17d33494cac
https://doi.org/10.1200/jco.2015.63.4238
https://doi.org/10.1200/jco.2015.63.4238
Autor:
Frans L. Opdam, E. Maartense, J Hartigh den, T. van der Straaten, C.J.H. van de Velde, H-J Guchelaar, Patrick Neven, Carolien H. Smorenburg, Hein Putter, Anne-Sophie Dieudonné, J.W.R. Nortier, Vincent O. Dezentjé, Hans Gelderblom, R. Vree
Publikováno v:
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 153(3), 583-590
Breast Cancer Research and Treatment, 153(3), 583-590
Breast cancer patients with absent or reduced CYP2D6 activity and consequently low endoxifen levels may benefit less from tamoxifen treatment. CYP2D6 poor and intermediate metabolizers may need a personalized increased tamoxifen dose to achieve effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::732642fc15ff09298d2b98bdbe40275c
http://europepmc.org/articles/PMC4589558
http://europepmc.org/articles/PMC4589558
Autor:
Harm P. Sleeboom, Monique M.E.M. Bos, N.I. Weijl, Koos J. M. van der Hoeven, Cornelis J. A. Punt, Paul K. J. Han, Frans Cluitmans, Ellen M. A. Smets, Patricia Quarles van Ufford-Mannesse, Judith R. Kroep, E. Maartense, F. J. Sherida H. Woei-A-Jin, Johanneke E.A. Portielje, Anne M. Stiggelbout, Hanneke C. J. M. de Haes, Nanny van Duijn-Bakker, Ellen G. Engelhardt, Arwen H. Pieterse
Publikováno v:
Medical Decision Making, 37(3), 179-192
Background. Treatment decision making is often guided by evidence-based probabilities, which may be presented to patients during consultations. These probabilities are intrinsically imperfect and embody 2 types of uncertainties: aleatory uncertainty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::571677c00bf6dc978d81cb1b4d078628
https://hdl.handle.net/1887/115981
https://hdl.handle.net/1887/115981
Autor:
Carolien H. Smorenburg, H. van Tinteren, A.E. van Leeuwen-Stok, M. Los, Johan W.R. Nortier, Jürgen Braun, Marije E. Hamaker, J G Schrama, Caroline Seynaeve, A.N.M. Wymenga, E. Maartense, H de Graaf, S. de Groot, F.E. de Jongh
Publikováno v:
The Breast, 23(1), 81-87
Breast, 23(1), 81-87. Churchill Livingstone
Breast, 23(1), 81-87. Churchill Livingstone
Aim: To evaluate the association between baseline comprehensive geriatric assessment (CGA) or the Groningen Frailty Indicator (GFI) and toxicity in elderly metastatic breast cancer (MBC) patients treated with first-line palliative chemotherapy. Patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c85b4b2f17cb7ff7b12cfdf781bb8a71
https://doi.org/10.1016/j.breast.2013.11.004
https://doi.org/10.1016/j.breast.2013.11.004
Autor:
E. Meershoek-Klein Kranenbarg, Judith R. Kroep, A. Charehbili, Birgit E.P.J. Vriens, Raem Tollenaar, Wouter Dercksen, L. J. C. van Warmerdam, G.J. Liefers, Tja Dekker, E. Maartense, MJ Pepels, Joan B. Heijns, Hwr Nortier, Wilma E. Mesker, Vthbm Smit, Cjh van de Velde, Hwm van Laarhoven, LW Kessels, M.N. Wasser
Publikováno v:
Cancer Research. 73:P1-06
Background Intra-tumoral stroma interacts with tumor cells and has a profound effect on tumor behavior. The tumor-stroma ratio (TSR) is of prognostic value in BC and other types of solid tumors. However, the predictive value of this parameter for ach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80c85ca2ab19e5c6a81402849d72c436
https://doi.org/10.1158/0008-5472.sabcs13-p1-06-04
https://doi.org/10.1158/0008-5472.sabcs13-p1-06-04
Autor:
Hwm van Laarhoven, Wouter Dercksen, Joan B. Heijns, G.J. Liefers, E van Leeuwen-Stok, LW Kessels, A. Charehbili, L. J. C. van Warmerdam, Vthbm Smit, MJ Pepels, E. Meershoek-Klein Kranenbarg, Judith R. Kroep, Birgit E.P.J. Vriens, Hein Putter, Nat Hamdy, E. Maartense, Cjh van de Velde, Hwr Nortier
Publikováno v:
Cancer Research. 73:P1-08
Background: Vitamin D (vit D) status is suggested to be of prognostic value for treatment outcome in women with breast cancer. However, there are no data of the predictive value of vit D status and changes of vit D levels for response to neoadjuvant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40c241bfc38f2a9846a75e5fd4c0e5f3
https://doi.org/10.1158/0008-5472.sabcs13-p1-08-19
https://doi.org/10.1158/0008-5472.sabcs13-p1-08-19
Autor:
Johanneke E.A. Portielje, Saskia le Cessie, Bea Tanis, Erik J. Giltay, E. Maartense, Ab A Aaldriks, Johan W. R. Nortier, Lydia G. M. van der Geest
Publikováno v:
Journal of Geriatric Oncology, 4(3), 218-226
In general, geriatric assessment (GA) provides the combined information on comorbidity and functional, nutritional and psychosocial status and may be predictive for mortality outcome of cancer patients. The impact of geriatric assessment on the outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89de354d93a949be6efa61713835d10a
https://doi.org/10.1016/j.jgo.2013.04.001
https://doi.org/10.1016/j.jgo.2013.04.001
Autor:
Caroline Seynaeve, B.C. van Munster, Epie Boven, M. Wymenga, E. Maartense, Johan W.R. Nortier, S.E. de Rooij, A.E. van Leeuwen-Stok, Carolien H. Smorenburg, Marije E. Hamaker
Publikováno v:
Breast (Edinburgh, Scotland), 22(4), 556-559. Churchill Livingstone
Breast, 22(4), 556-559. Churchill Livingstone
Hamaker, M E, Seynaeve, C, Nortier, J W R, Wymenga, M, Maartense, E, Boven, E, van Leeuwen-Stok, A E, Rooij, S E, van Munster, B C & Smorenburg, C H 2013, ' Slow accrual of elderly patients with metastatic breast cancer in the Dutch multicentre OMEGA study ', Breast, vol. 22, no. 4, pp. 556-559 . https://doi.org/10.1016/j.breast.2012.12.010
The Breast, 22(4), 556-559
Breast, 22(4), 556-559. Churchill Livingstone
Hamaker, M E, Seynaeve, C, Nortier, J W R, Wymenga, M, Maartense, E, Boven, E, van Leeuwen-Stok, A E, Rooij, S E, van Munster, B C & Smorenburg, C H 2013, ' Slow accrual of elderly patients with metastatic breast cancer in the Dutch multicentre OMEGA study ', Breast, vol. 22, no. 4, pp. 556-559 . https://doi.org/10.1016/j.breast.2012.12.010
The Breast, 22(4), 556-559
Background In a Dutch multicentre study, elderly (65 + year) metastatic breast cancer patients, eligible for first-line chemotherapy, were randomised between two types of single-agent chemotherapy. As accrual was slow, with 78 randomised patients bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d07293f54ff1b795c2c5dff578ba6eaf
https://doi.org/10.1016/j.breast.2012.12.010
https://doi.org/10.1016/j.breast.2012.12.010